Serum phospholipid monounsaturated fatty acid composition and δ-9-desaturase activity are associated with early alteration of fasting glycemic status

Nutrition Research

Volumn 34, Issue 9, 2014, Pages 733-741

  Cho, Jae Sun ^a,b   Baek, Seung Han ^a   Kim, Ji Young ^c   Lee, Jong Ho ^a   Kim, Oh Yoen ^b  

^a Yonsei University   (South Korea)

^b Dong A University   (South Korea)

^c Woosong University   (South Korea)

Author keywords

Cardiometabolic risk; Fasting glycemic status; Human; Monounsaturated fatty acid; Oleic acid; 9 desaturase

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ACYL COENZYME A DESATURASE; ADIPONECTIN; C REACTIVE PROTEIN; DIHOMO GAMMA LINOLENIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; OLEIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; PALMITOLEIC ACID; 8-EPI-PROSTAGLANDIN F2ALPHA; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; PROSTAGLANDIN F2 ALPHA; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ENERGY EXPENDITURE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FATTY ACID BLOOD LEVEL; FEMALE; FOOD INTAKE; GENDER; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID COMPOSITION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ANALOGS AND DERIVATIVES; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; DIABETES MELLITUS, TYPE 2; METABOLISM; MIDDLE AGED;

8,11,14-EICOSATRIENOIC ACID; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DINOPROST; FASTING; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LINOLEIC ACID; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OLEIC ACID; PHOSPHOLIPIDS; STEAROYL-COA DESATURASE; TRIGLYCERIDES;

EID: 84921968719     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2014.08.005     Document Type: Article

References (43)

1. Kim O.Y., Lim H.H., Lee M.J., Kim J.Y., Lee J.H. Association of fatty acid composition in serum phospholipids with metabolic syndrome and arterial stiffness. Nutr Metab Cardiovasc Dis 2013, 23:366-374.
2. Warensjö E., Ohrvall M., Vessby B. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis 2006, 16:128-136.
3. Warensjö E., Sundström J., Vessby B., Cederholm T., Risérus U. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr 2008, 88:203-209.
4. Hooper L., Thompson R.L., Harrison R.A., Summerbell C.D., Ness A.R., Moore H.J., et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 2006, 332:752-760.
5. Dougherty R.M., Galli C., Ferro-Luzzi A., Iacono J.M. Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA. Am J Clin Nutr 1987, 45:443-455.
6. Ma J., Folsom A.R., Shahar E., Eckfeldt J.H. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Clin Nutr 1995, 62:564-571.
7. Vessby B. Dietary fat and insulin action in humans. Br J Nutr 2000, 83(Suppl. 1):S91-S96.
8. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003, 14:15-19.
9. Leeson C.P., Mann A., Kattenhorn M., Deanfield J.E., Lucas A., Muller D.P. Relationship between circulating n-3 fatty acid concentrations and endothelial function in early adulthood. Eur Heart J 2002, 23:216-222.
10. Ntambi J.M., Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res 2004, 43:91-104.
11. Listenberger L.L., Schaffer J.E. Mechanisms of lipoapoptosis: implications for human heart disease. Trends Cardiovasc Med 2002, 12:134-138.
12. Coll T., Eyre E., Rodriguez-Calvo R., Palomer X., Sanchez R.M., Merlos M., et al. Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J Biol Chem 2008, 283:11107-11116.
13. Yao-Borengasser A., Rassouli N., Varma V., Bodles A.M., Rasouli N., Unal R., et al. Stearoyl-coenzyme a desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-γ responsiveness. J Clin Endocrinol Metab 2008, 93:4431-4439.
14. Van Woudenbergh G.J., Kuijsten A., Van der Kallen C.J., Van Greevenbroek M.M., Stehouwer C.D., Blaak E.E., et al. Comparison of fatty acid proportions in serum cholesteryl esters among people with different glucose tolerance status: the CoDAM study. Nutr Metab Cardiovasc Dis 2012, 22:133-140.
15. Ortinau L.C., Pickering R.T., Nickelson K.J., Stromsdorfer K.L., Naik C.Y., Haynes R.A., et al. Sterculic oil, a natural SCD1 inhibitor, improves glucose tolerance in obese ob/ob Mice. ISRN Endocrinol 2012, 20:1-11. [947323].
16. Schwingshackl L., Strasser B., Hoffmann G. Effect of monounsaturated fatty acids on glycaemic control in patients with abnormal glucose metabolism: a systematic review and meta-analysis. Ann Nutr Metab 2011, 58:290-296.
17. Schwingshackl L., Strasser B. High-MUFA diets reduce fasting glucose in patients with type 2 diabetes. Ann Nutr Metab 2012, 60:33-34.
18. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
19. World Health Organization The Asian Pacific perspective: redefining obesity and its treatment 2000, Health Communications Australia Pty Ltd.
20. American Diabetes Association Standards of medical care in diabetes-2010. Diabetes Care 2010, 33:s11-s61.
21. Song J., Kwon N., Lee M.H., Koh Y., Lee J.H., Kim O.Y. Association of serum phospholipid PUFAs with cardiometabolic risk: beneficial effect of DHA on the suppression of vascular proliferation/inflammation. Clin Biochem 2014, 47:361-368.
22. Kwak J.H., Paik J.K., Kim H.I., Kim O.Y., Shin D.Y., Kim H.J., et al. Dietary treatment with rice containing resistant starch improves markers of endothelial function with reduction of postprandial blood glucose and oxidative stress in patients with prediabetes or newly diagnosed type 2 diabetes. Atherosclerosis 2012, 224:457-464.
23. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
24. Lepage G., Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986, 27:114-120.
25. Li Y., Seifert M.F., Lim S.Y., Salem N., Watkins B.A. Bone mineral content is positively correlated to n-3 fatty acids in the femur of growing rats. Br J Nutr 2010, 104:674-685.
26. Matthan N.R., Ip B., Resteghini N., Ausman L.M., Lichtenstein A.H. Long-term fatty acid stability in human serum cholesteryl ester, triglyceride, and phospholipid fractions. J Lipid Res 2010, 51:2826-2832.
27. Shim J.S., Oh K.W., Suh I., Kim M.Y., Shon C.Y., Lee E.J. A study on validity of a 299 semiquantitative food frequency questionnaire of Korean adults. Korean J Community Nutr 2002, 7:484-494.
28. Ntambi J.M., Miyazaki M., Stoehr J.P. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A 2002, 99:11482-11486.
29. Gutíerrez-Júarez R., Pocai A., Mulas C. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J Clin Invest 2006, 116:1686-1695.
30. Dobrzyn P., Dobrzyn A., Miyazaki M. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci U S A 2004, 101:6409-6414.
31. Miyazaki M., Dobrzyn A., Sampath H. Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-α. J Biol Chem 2004, 279:35017-35024.
32. Hyun C.K., Kim E.D., Flowers M.T. Adipose specific deletion of stearoyl-CoA desaturase 1 up-regulates the glucose transporter GLUT1 in adipose tissue. Biochem Biophys Res Commun 2012, 399:480-486.
33. Miyazaki M., Flowers M.T., Sampath H. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab 2007, 6:484-496.
34. Miyazaki M., Sampath H., Liu X. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice. Biochem Biophys Res Commun 2009, 380:818-822.
35. Carpino P.A., Goodwin B. Diabetes area participation analysis: a review of companies and targets described in the 2008-2010 patent literature. Expert Opin Ther Pat 2010, 20:1627-1651.
36. Phinney S.D. Fatty acids, inflammation, and the metabolic syndrome. Am J Clin Nutr 2005, 82:1151-1152.
37. Louheranta A.M., Sarkkinen E.S., Vidgren H.M., Schwab U.S., Uusitupa M.I. Association of the fatty acid profile of serum lipids with glucose and insulin metabolism during 2 fat-modified diets in subjects with impaired glucose tolerance. Am J Clin Nutr 2002, 76:331-337.
38. Ryan M., McInerney D., Owens D., Collins P., Johnson A., Tomkin G.H. Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium-dependent Diabetes and the Mediterranean diet dent vasoreactivity. QJM 2000, 93:85-91.
39. Mayer-Davis E.J., Monaco J.H., Hoen H.M., Carmichael S., Vitolins M.Z., Rewers M.J., et al. Dietary fat and insulin sensitivity in a triethnic population: the role of obesity the insulin resistance atherosclerosis study (IRAS). Am J Clin Nutr 1997, 65:79-87.
40. Lovejoy J.C., Smith S.R., Champagne C.M., Most M.M., Lefevre M., DeLany J.P., et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 2002, 25:1283-1288.
41. Hekmatdoost A., Mirmiran P., Hosseini-Esfahani F., Azizi F. Dietary fatty acid composition and metabolic syndrome in Tehranian adults. Nutrition 2011, 27:1002-1007.
42. Ralston J.C., Zulyniak M.A., Nielsen D.E., Clarke S., Badawi A., El-Sohemy A., et al. Ethnic- and sex-specific associations between plasma fatty acids and markers of insulin resistance in healthy young adults. Nutr Metab 2013, 17:10-42.
43. Feskens E.J.M., Stengård J., Virtanen S.M., Tuomilehto J., Stengård J., Pekkanen J., et al. Dietary factors determining diabetes and impaired glucose tolerance: a 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 1995, 18:1104-1112.